- June 11, 2026
Reasons to Invest in Art in 2023 and Beyond
[ad_1] The global art market is enormous. in 2022 its annual sale value was a whopping 68 billion US dollars. And the UK is one
The art of keeping it simple, by JPMorgan’s Jan Loeys
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. JPMorgan has 240,000 employees
New ways to purchase the passion investment of art
[ad_1] Published on September 25, 2023 There are now new pathways to art ownership that include private syndicates and immersive art fairs for investors. The
Taxes and Art” and Richard H. Rush’s “Art as an Investment
[ad_1] “Taxes and Art” and Richard H. Rush’s “Art as an Investment” ad [ad_2] Source link
New ‘state-of-the-art’ East Yorkshire manufacturing facility to create over 400 jobs
[ad_1] Property developer Wykeland Group has exchanged on a deal to pave the way for an investment of several hundreds of millions of pounds to
Leak reveals majority interest in Roman Abramovich’s nearly $1 billion art collection was transferred to his ex-wife ahead of sanctions
[ad_1] An offshore trust controlling Russian billionaire Roman Abramovich’s vast art collection was amended to make his ex-wife, art collector Dasha Zhukova, its majority beneficiary
Oprah Winfrey Made A $62 Million Profit On High-Profile Investment — And You Don’t Need To Be A Billionaire To Do It
[ad_1] Media tycoon and self-made billionaire Oprah Winfrey made a name for herself not only in television but also in fine art. A few years
Is art a good investment? Experts weigh in on stock markets for artwork
[ad_1] Paul Solman: The usual minimum investment, $15,000, for shares of an artwork whose price is derived from an auction database tracking 7000 artists post-World
Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee, Co. Kerry. Ireland
[ad_1] – Investment will build capabilities to supply the Astellas global market and accelerate the development and commercialisation of innovative medicines – TOKYO, Sept. 14,